Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 58 results for "ranjit kapadia"

Lupin: Earnings upgrades likely after stellar Q1

Experts bullish on Lupin after stellar Q1 performance

A Speaking to CNBC-TV18 post the result, Ranjit Kapadia of Centrum Broking expects Lupin to report a good performance on domestic front as well just like its peers Ranbaxy and Pfizer. He is highly bullish on the stocks backed by its strong Q1 ..., 1 day ago
Lupin: Earnings upgrades likely after stellar Q1 Smart Investor, 8 hours ago

4 images for ranjit kapadia, 3 months ago, 3 months ago
Money Control, 4 months ago, 5 months ago

Sell Ranbaxy; Sun Pharma may test Rs 780: Ranjit Kapadia

Ranjit Kapadia of Centrum Broking is of the view that Sun Pharmaceutical Industries may test Rs 780.
 Money Control1 month ago Sun Pharma buys US drug maker  Smart Investor2 weeks ago Sun Pharma buys US-based injectable firm Pharmalucence  DNA India2 weeks ago Sun Pharma buys US injectables company  Hindu Business Line2 weeks ago

Sun's Shanghvi Emerges as Top Drug Billionaire: Chart of the Day

Dilip Shanghvi has emerged as the world's wealthiest drug baron, as his planned takeover of Ranbaxy Laboratories Ltd. by Sun Pharmaceutical Industries Ltd. helped add $5.3 billion to his fortune this year. The CHART OF THE DAY tracks Sun Pharma ...
 Bloomberg1 day ago
Bar & Bench

After J. Ashok Kumar, Katju guns for ex-CJI Balakrishnan, former Karnataka Chief Justice P.New

Weeks after alleging that an Additional Judge of the Madras High Court was made a Permanent Judge despite the presence of adverse findings , former Supreme Court judge J. Katju has now aimed his sights on the former Chief Justice of India and ...
 Bar & Bench3 days ago

Pharma stocks could rise another 15-20%

The pharmaceutical sector has been one of the highest sectoral gainers in recent weeks, with six of the top 10 stocks by market capitalisation touching their all-time highs in July. Expectations of a strong performance in the June quarter, ahead of the results announcement by top pharma companies this week, has been one reason for the price surge. In addition, consistent performance and preference of investors for stocks in the defensive space helped the sector outshine the broader markets. ...
 Rediff.com3 days ago Downtrend in pharma stocks may remain over next one month  DNA India2 months ago
DNA India

NPPA moves to bring cancer drugs under price control regime

Mumbai : The National Pharmaceutical Pricing Authority (NPPA) is moving fast on reducing prices of cancer drugs. It has pulled up six pharma companies, including Ranbaxy , Biocon , Cipla and Pfizer, for not providing pricing data of cancer drugs ...
 4 Traders1 week ago National Pharmaceutical Pricing Authority moves to bring cancer drugs under price control  DNA India1 week ago Pharma companies face Rs 570 crore hit on fresh price cap  DNA India2 weeks ago

No major worries for Lupin

The European anti-trust commission's imposing a Rs 324-crore fine on Lupin failed to deter investor sentiments. In fact, the stock has traded two per cent higher on the bourses since the news broke. Reason: the company's strong domestic and export ...
 Business Standard India2 weeks ago

Diovan generic may fetch Ranbaxy $150 mn revenue: Centrum

There are host of players which are already there with Diovan HCT, seven players are already there in the market with a combination, so upside for Ranbaxy will be limited, says Ranjit Kapadia of Centrum Broking
 Money Control1 month ago

Full text: Gopal Subramaniam's Letter to Chief Justice

The following is the full text of the nine-page letter of former Solicitor General Gopal Subramanium to Chief Justice of India Justice Rajendra Mal Lodha, in which he has withdrawn his candidature as the judge of the Supreme Court. Respected Chief Justice, I ...
 Deccan Herald1 month ago

New Indian government looks to help small players finance upgrades

FDA actions against Indian drug manufacturers have not gone unnoticed by the country's newly elected Prime Minister Narendra Modi, and he has a plan to do something about it. A likely approach is a subsidy program for smaller manufacturers that ...
 FiercePharmaManufacturing1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less